Dr. Joseph Leventhal, MD

NPI: 1124050406
Total Payments
$36,929
2024 Payments
$475.00
Companies
9
Transactions
43
Medicare Patients
278
Medicare Billing
$105,961

Payment Breakdown by Category

Other$15,240 (41.3%)
Travel$14,615 (39.6%)
Consulting$4,475 (12.1%)
Food & Beverage$2,588 (7.0%)
Education$10.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $14,615 9 39.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,730 11 34.5%
Consulting Fee $4,475 3 12.1%
Food and Beverage $2,588 16 7.0%
Honoraria $2,510 2 6.8%
Education $10.00 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Veloxis Pharmaceuticals, Inc. $32,345 32 $0 (2022)
Astellas Pharma US Inc $3,250 2 $0 (2017)
ZOLL Medical Corporation $475.00 1 $0 (2024)
CSL Behring $287.48 3 $0 (2018)
PFIZER INC. $220.00 1 $0 (2018)
E.R. Squibb & Sons, L.L.C. $120.52 1 $0 (2019)
Novartis Pharmaceuticals Corporation $106.58 1 $0 (2017)
Intuitive Surgical, Inc. $77.90 1 $0 (2019)
Medical Device Business Services, Inc. $46.73 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $475.00 1 ZOLL Medical Corporation ($475.00)
2022 $2,510 2 Veloxis Pharmaceuticals, Inc. ($2,510)
2020 $6,810 5 Veloxis Pharmaceuticals, Inc. ($6,810)
2019 $14,597 16 Veloxis Pharmaceuticals, Inc. ($14,398)
2018 $5,519 6 Veloxis Pharmaceuticals, Inc. ($5,248)
2017 $7,018 13 Veloxis Pharmaceuticals, Inc. ($3,378)

All Payment Transactions

43 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
01/30/2024 ZOLL Medical Corporation Defibrillator (Device) Consulting Fee Cash or cash equivalent $475.00 General
Category: Resuscitation
06/02/2022 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Honoraria Cash or cash equivalent $2,010.00 General
Category: Immunosuppresant
03/15/2022 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Honoraria Cash or cash equivalent $500.00 General
Category: Immunosuppresant
07/09/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,150.00 General
Category: Immunosuppressant
05/07/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Consulting Fee Cash or cash equivalent $1,000.00 General
Category: Immunosuppressant
02/12/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: Immunosuppressant
02/12/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Travel and Lodging Cash or cash equivalent $1,554.70 General
Category: Immunosuppressant
02/12/2020 Veloxis Pharmaceuticals, Inc. Envarsus (Drug) Travel and Lodging Cash or cash equivalent $105.27 General
Category: Immunosuppressant
07/31/2019 E.R. Squibb & Sons, L.L.C. NULOJIX (Biological) Food and Beverage Cash or cash equivalent $120.52 General
Category: Immunology
06/02/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Travel and Lodging In-kind items and services $2,500.00 General
Category: Immunosuppressant
04/12/2019 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $77.90 General
Category: SURGERY
04/09/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Travel and Lodging In-kind items and services $2,500.00 General
Category: Immunosuppressant
04/09/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $41.68 General
Category: Immunosuppressant
04/09/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $26.10 General
Category: Immunosuppressant
03/12/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Travel and Lodging In-kind items and services $2,500.00 General
Category: Immunosuppressant
03/12/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Travel and Lodging In-kind items and services $1,644.29 General
Category: Immunosuppressant
03/12/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $134.25 General
Category: Immunosuppressant
03/12/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $104.19 General
Category: Immunosuppressant
02/27/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Food and Beverage In-kind items and services $479.59 General
Category: Immunosuppressant
02/06/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Travel and Lodging In-kind items and services $2,500.00 General
Category: Immunosuppressant
02/06/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Food and Beverage In-kind items and services $173.81 General
Category: Immunosuppressant
02/06/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $124.01 General
Category: Immunosuppressant
01/31/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Travel and Lodging In-kind items and services $1,250.00 General
Category: Immunosuppressant
01/31/2019 Veloxis Pharmaceuticals, Inc. Envarsus (Drug), Envarsus Food and Beverage In-kind items and services $420.31 General
Category: Immunosuppressant
06/09/2018 PFIZER INC. Food and Beverage In-kind items and services $220.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 16 27 $5,859 $1,827
2022 1 17 25 $5,425 $1,474
2021 6 119 175 $235,350 $45,324
2020 3 126 253 $280,860 $57,336
Total Patients
278
Total Services
480
Medicare Billing
$105,961
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 16 27 $5,859 $1,827 31.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 17 25 $5,425 $1,474 27.2%
50360 Transplantation of donor kidney Facility 2021 15 15 $178,260 $33,766 18.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 50 106 $23,002 $6,413 27.9%
50323 Preparation of donor kidney for transplantation Facility 2021 13 13 $14,300 $1,506 10.5%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 12 12 $4,020 $1,397 34.8%
50327 Preparation of donor kidney for transplantation, venous connection Facility 2021 11 11 $11,880 $1,130 9.5%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 18 18 $3,888 $1,112 28.6%
50360 Transplantation of donor kidney Facility 2020 21 21 $230,550 $43,647 18.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 71 198 $42,966 $11,656 27.1%
99238 Hospital discharge day management, 30 minutes or less Facility 2020 34 34 $7,344 $2,033 27.7%

About Dr. Joseph Leventhal, MD

Dr. Joseph Leventhal, MD is a Transplant Surgery healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124050406.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Leventhal, MD has received a total of $36,929 in payments from pharmaceutical and medical device companies, with $475.00 received in 2024. These payments were reported across 43 transactions from 9 companies. The most common payment nature is "Travel and Lodging" ($14,615).

As a Medicare-enrolled provider, Leventhal has provided services to 278 Medicare beneficiaries, totaling 480 services with total Medicare billing of $105,961. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Transplant Surgery
  • Location Chicago, IL
  • Active Since 07/07/2006
  • Last Updated 02/12/2020
  • Taxonomy Code 204F00000X
  • Entity Type Individual
  • NPI Number 1124050406

Products in Payments

  • Envarsus (Drug) $23,718
  • Envarsus XR (SP) (Drug) $5,248
  • Envarsus XR (Drug) $3,378
  • Defibrillator (Device) $475.00
  • Product in Development (Biological) $236.74
  • NULOJIX (Biological) $120.52
  • Da Vinci Surgical System (Device) $77.90
  • EVARREST (Biological) $46.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Transplant Surgery Doctors in Chicago